Gene expression profiling of gliomas: merging genomic and histopathological classification for personalised therapy.
about
Recent advances in the molecular understanding of glioblastomaTargeting Aggressive Cancer Stem Cells in GlioblastomaMolecular characterizations of glioblastoma, targeted therapy, and clinical results to dateContemporary murine models in preclinical astrocytoma drug developmentMolecular Markers in Low-Grade Glioma-Toward Tumor ReclassificationDrug Repositioning through Systematic Mining of Gene Coexpression Networks in CancerThe art of attraction: applications of multifunctional magnetic nanomaterials for malignant glioma.Application of iron oxide nanoparticles in glioma imaging and therapy: from bench to bedside.Transcriptional profiling of formalin fixed paraffin embedded tissue: pitfalls and recommendations for identifying biologically relevant changes.Investigation of adhesion and mechanical properties of human glioma cells by single cell force spectroscopy and atomic force microscopy.A mathematical model for short-term vs. long-term survival in patients with glioma.Logic Learning Machine creates explicit and stable rules stratifying neuroblastoma patientsTranscriptional analysis of aggressiveness and heterogeneity across grades of astrocytomas.Altered expression of polycomb group genes in glioblastoma multiforme.Molecular profiling indicates orthotopic xenograft of glioma cell lines simulate a subclass of human glioblastoma.Whole genome sequencing of glioblastoma multiforme identifies multiple structural variations involved in EGFR activationIntegrated microRNA-mRNA analysis revealing the potential roles of microRNAs in tongue squamous cell cancer.Molecular classification of gliomas based on whole genome gene expression: a systematic report of 225 samples from the Chinese Glioma Cooperative GroupPretreatment Dynamic Susceptibility Contrast MRI Perfusion in Glioblastoma: Prediction of EGFR Gene Amplification.Frontiers in Suicide Gene Therapy of Cancer.Role of Biomarkers in the Clinical Management of Glioblastomas: What are the Barriers and How Can We Overcome Them?CD151-α3β1 integrin complexes are prognostic markers of glioblastoma and cooperate with EGFR to drive tumor cell motility and invasion.Integrative physical oncologyDeletion and low expression of NFKBIA are associated with poor prognosis in lower-grade glioma patients.Sox11 expression in astrocytic gliomas: correlation with nestin/c-Met/IDH1-R132H expression phenotypes, p-Stat-3 and survivalCore pathway mutations induce de-differentiation of murine astrocytes into glioblastoma stem cells that are sensitive to radiation but resistant to temozolomide.Evolutionary etiology of high-grade astrocytomas.Glioblastoma: Overview of Disease and Treatment.Induced interleukin-33 expression enhances the tumorigenic activity of rat glioma cells.Malignant glioma: lessons from genomics, mouse models, and stem cells.Improving drug delivery to primary and metastatic brain tumors: strategies to overcome the blood-brain barrier.An integrated analysis of the effects of microRNA and mRNA on esophageal squamous cell carcinomaImmune microenvironment of gliomas.Modeling astrocytoma pathogenesis in vitro and in vivo using cortical astrocytes or neural stem cells from conditional, genetically engineered mice.TRIM3, a tumor suppressor linked to regulation of p21(Waf1/Cip1.).The renal v-ATPase a4 subunit is expressed in specific subtypes of human gliomas.Microarray analysis in a cell death resistant glioma cell line to identify signaling pathways and novel genes controlling resistance and malignancy.Neither P-gp SNP variants, P-gp expression nor functional P-gp activity predicts MDR in a preliminary study of plasma cell myeloma.Pushing the limits of glioma resection using electrophysiologic brain mappingPDGF Family Expression in Glioblastoma Multiforme: Data Compilation from Ivy Glioblastoma Atlas Project Database.
P2860
Q24632928-40211ADB-ECDB-47C2-95A2-6E2F284E7882Q26799983-87AA8053-3DA8-43E7-85D3-47D83319D7A1Q26822717-3A49F2A0-A7E2-451A-ABEA-F3B6AAE2D65CQ27026937-D7C02A17-FC44-44F4-A64A-BA07C22690A0Q28383205-8F8F4250-22EF-40B7-949F-EBDE14159940Q28553245-B58E4ECD-0A43-4D2E-A201-9FB20181EE6FQ30809060-9A3C93F8-DB8A-4ECF-A41D-78F1E5AB1C2AQ31065446-49AA0621-D274-4D63-9A49-7247AFB3C865Q34243648-0039EDA7-402B-42A7-AAD9-D786BE92CBB4Q34497830-57514F1E-20E3-47CA-A898-0C52B53CBE5FQ34704964-351AA029-37B5-4384-9748-E39141355BD4Q34787791-37AC32E7-A9E0-4C84-BD67-B10C2967A8FAQ35022908-3CBC5B15-323D-4A3C-A892-A254A25126B6Q35049386-94A88AF2-6A06-48E4-9CC8-C96DF749F765Q35190165-AA17E97B-C446-4CD9-AF31-0A0F54929A77Q35221471-FBB6EE7B-C398-466A-83A7-801557814178Q35628524-AF247B14-636C-4AA7-85A5-29CB0EDBF384Q36401841-184E65B9-F161-468F-A1C4-6CE22A12A9AAQ36459981-7B0B8AAF-6B28-4D2E-A3EA-4D007875735FQ36534930-756992C9-D5E4-4A60-BFA6-7496ECD49B4FQ36542980-8E5BD935-4BE5-4B35-AFA1-95E7B8E3D74EQ36557409-8B02DA9C-7334-43D3-9782-EC81E18133C8Q36754194-E1C70077-2989-424A-8275-7ACE174252C6Q36774118-7D085E15-D39B-4B52-9372-C1D0802DD466Q36896197-B3D45133-F960-430C-B90A-1C2B9EEBA893Q36977690-2201B0D1-5489-4097-AB9E-1174A5D0A3DEQ37276702-2E20957C-9549-44FF-85FF-3AD9790082DCQ37441791-7F5E38B6-B936-4F19-A6C7-091C27E5D228Q37641240-E415D360-436A-4070-A56B-4134B10E1789Q37998643-A94E3754-7039-444F-B814-72AA5919F210Q38351134-21D6CD9D-6C3D-45A8-B756-8094F33782D0Q38465175-06253C8C-8841-49AB-8894-86F7C6487655Q38712457-CF1B41FB-307B-472A-91BE-777B07D29A98Q38963855-57728A93-B552-4049-9DCD-517212D35086Q39210791-47BE3D1F-5E6F-42F1-9329-5EFFC7DDF6F1Q39372069-6D4CBA11-256F-4BCB-9AA6-3D0E24C04F48Q39614127-C4DA637A-FA6D-4B21-A3E8-58BB1C4717C1Q39638448-0C37A183-BC91-4EBB-893C-CBCF4F8B9727Q42367453-C6C9B3EC-78E7-4865-B3EA-8773F510AE19Q47131994-9C5D54DF-4B95-4122-B91B-610FD92FAA33
P2860
Gene expression profiling of gliomas: merging genomic and histopathological classification for personalised therapy.
description
2010 nî lūn-bûn
@nan
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
2010年论文
@zh
2010年论文
@zh-cn
name
Gene expression profiling of g ...... tion for personalised therapy.
@ast
Gene expression profiling of g ...... tion for personalised therapy.
@en
Gene expression profiling of g ...... tion for personalised therapy.
@nl
type
label
Gene expression profiling of g ...... tion for personalised therapy.
@ast
Gene expression profiling of g ...... tion for personalised therapy.
@en
Gene expression profiling of g ...... tion for personalised therapy.
@nl
prefLabel
Gene expression profiling of g ...... tion for personalised therapy.
@ast
Gene expression profiling of g ...... tion for personalised therapy.
@en
Gene expression profiling of g ...... tion for personalised therapy.
@nl
P2860
P921
P356
P1476
Gene expression profiling of g ...... ation for personalised therapy
@en
P2093
P2860
P2888
P304
P356
10.1038/SJ.BJC.6606031
P407
P577
2010-11-30T00:00:00Z
P5875
P6179
1034677098